Key result
Higher endothelin-1 linked to ~81% higher incident CKD risk in Black adults.
Why the study?
It is not known whether elevated serum levels of endothelin-1 indicate future risk of kidney disease in the general population.
Are higher baseline serum endothelin-1 levels associated with an increased risk of incident CKD and all-cause mortality in black adults?
Observational (n=3,538)
Are higher baseline serum endothelin-1 levels associated with an increased risk of incident CKD and all-cause mortality in black adults?
Higher baseline serum endothelin-1 levels are associated with an increased risk of incident chronic kidney disease and all-cause mortality in black adults.
Answers are grounded in this paper and cite their sources.
Endothelin-1 may stratify CKD risk in black adults; hypothesis-generating and should not yet change practice.
Endothelin-1, a marker of endothelial dysfunction, is a potent vasoconstrictor released by endothelial cells and an important regulator of renal physiology. It is not known whether elevated serum levels of endothelin-1 indicate future risk of kidney disease in the general population. In participants in the Jackson Heart Study, a community-based observational study of cardiovascular risk in black adults, we measured serum endothelin-1 level at baseline (2000–2004; n =3538). We defined incident CKD as eGFR<60 ml/min per 1.73 m 2 and ≥30% eGFR decline at the third visit (2009–2013) relative to baseline among those participants with baseline eGFR ≥60 ml/min per 1.73 m 2 . At baseline, mean age was 55 years old, 37% of participants were men, and mean eGFR was 94 ml/min per 1.73 m 2 . Over a median follow-up of 8 years, 228 (6.4%) cases of incident CKD occurred in participants. Participants with baseline endothelin-1 levels in higher quartiles had a greater incidence of CKD in the fully adjusted model (odds ratio for fourth versus first quartile, 1.81; 95% confidence interval, 1.11 to 2.96; P trend =0.04). Endothelin-1 positively associated with all-cause mortality (hazard ratio for fourth versus first quartile, 1.64; 95% confidence interval, 1.24 to 2.16; P trend <0.001). In conclusion, higher baseline serum endothelin-1 levels associated with incident CKD and all-cause mortality during follow-up in this general population sample of blacks.
No takes yet. Share an insight, caveat, or question.
Rebholz et al. (2017) conducted an observational in Kidney disease (n=3,538). Elevated serum endothelin-1 levels vs. Lower serum endothelin-1 levels (first quartile) was evaluated on Incident CKD (eGFR<60 ml/min per 1.73 m2 and ≥30% eGFR decline) (OR 1.81, 95% CI 1.11 to 2.96, p=0.04). Higher baseline serum endothelin-1 levels (fourth vs first quartile) were associated with a greater incidence of CKD and all-cause mortality in black adults.
Synapse has enriched 10 related papers. Consider them for comparative context: